OFM

Omega Fund Management Portfolio holdings

AUM $154M
This Quarter Return
-0.68%
1 Year Return
-32.78%
3 Year Return
+82.35%
5 Year Return
+29.08%
10 Year Return
+90.46%
AUM
$211M
AUM Growth
+$211M
Cap. Flow
+$82.2M
Cap. Flow %
38.87%
Top 10 Hldgs %
95.05%
Holding
14
New
1
Increased
–
Reduced
1
Closed
–

Top Buys

1
REPL icon
Replimune Group
REPL
$82.2M

Top Sells

1
OBSV
ObsEva SA Ordinary Shares
OBSV
$5.41K

Sector Composition

1 Healthcare 98.39%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
REPL icon
1
Replimune Group
REPL
$422M
$82.2M 38.87% +5,103,455 New +$82.2M
PRTK
2
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$25.2M 11.93% 2,600,410 – –
TBIO
3
DELISTED
Translate Bio, Inc. Common Stock
TBIO
$24.4M 11.53% 2,437,601 – –
OBSV
4
DELISTED
ObsEva SA Ordinary Shares
OBSV
$18M 8.52% 999,364 -300 -0% -$5.41K
KZR icon
5
Kezar Life Sciences
KZR
$28.9M
$14.8M 7.02% 693,272 – –
SNNA
6
DELISTED
Sienna Biopharmaceuticals, Inc.
SNNA
$11.2M 5.32% 758,610 – –
FGEN icon
7
FibroGen
FGEN
$47.8M
$7.94M 3.75% 130,646 – –
CDTX icon
8
Cidara Therapeutics
CDTX
$1.66B
$6.64M 3.14% 1,508,794 – –
CBAY
9
DELISTED
Cymabay Therapeutics
CBAY
$6.11M 2.89% 551,477 – –
PVLA
10
Palvella Therapeutics, Inc. Common Stock
PVLA
$599M
$4.36M 2.06% 778,230 – –
JNCE
11
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$3.45M 1.63% 529,965 – –
DRNA
12
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$3.41M 1.61% 223,457 – –
EPIX icon
13
ESSA Pharma
EPIX
$11.4M
$3.26M 1.54% 1,084,848 – –
EGLT
14
DELISTED
Egalet Corporation
EGLT
$359K 0.17% 2,889,926 – –